Lung-MAP

1.5K posts

Lung-MAP banner
Lung-MAP

Lung-MAP

@LungMAP

A lung cancer precision medicine trial and unique partnership of @theNCI @CancerResrch @FNIH_org and @SWOG Testing new treatments, including immunotherapies.

Katılım Mart 2014
236 Takip Edilen1.1K Takipçiler
Lung-MAP retweetledi
Friends of Cancer Research
Friends of Cancer Research@CancerResrch·
The worst clinical trials are those that don’t complete themselves. - Raymond Osarogiagbon (@BaptistOnline) speaking on our "Control Arm Selection for Multi-Regional Clinical Trials" panel #FriendsAM25
Friends of Cancer Research tweet media
English
0
1
1
157
Lung-MAP retweetledi
Exon 20 Group, a multistakeholder organization
Exon 20 Group, a multistakeholder organization@Exon20Group·
We salute these three thoracic cancer stars for the tremendous advances Lung MAP has produced, and special kudos to @KarenReckampMD and Mary Redman, too! @LungMAP @FNIH_Org
David Gandara@drgandara

At Lung MAP master protocol meeting "the three amigos" ride again. Much accomplished, more to do. A key to success: flexibility of the Lung MAP platform to evolve as needed to address the rapidly changing diagnostic and the therapeutic landscape of NSCLC.@LungMAP @FNIH_Org

English
0
2
8
726
Lung-MAP retweetledi
David Gandara
David Gandara@drgandara·
At Lung MAP master protocol meeting "the three amigos" ride again. Much accomplished, more to do. A key to success: flexibility of the Lung MAP platform to evolve as needed to address the rapidly changing diagnostic and the therapeutic landscape of NSCLC.@LungMAP @FNIH_Org
David Gandara tweet media
English
3
6
50
2.4K
Lung-MAP retweetledi
David Gandara
David Gandara@drgandara·
Honored to present Translational Therapy seminar @OSUCCC on Convergence of Precision Oncology & Liquid Biopsy. Included our recent work on impact of tumor fraction (TF) for concordance of tissue/plasma ctDNA & association with NSCLC survival ( Mack et al. CCR 2025) @LungMAP
David Gandara tweet media
Triparna Sen (Sen-Lab)@triparnasen

Such a pleasure to be in the audience when @drgandara speaks! Always a treat to hear from someone who has contributed so much to advancing #lungcancer #research and #treatment. Honored to have him as a #mentor and grateful for his visit to @OSUCCC_James for the #Translational #Therapeutics Seminar Series. Thank you again for visiting us! It was wonderful to spend time together with him and our amazing #thoracic team, and yes, I even got to take a picture with two Davids (@DCarboneMD)🙂 . @BobakParang @JineshGheeya @ChristianRolfo @OhioStateMedOnc @OhioState @OncLive @OncoAlert @oncodaily #lungcancer #oncology #cancerresearch #thoraciconcology #mentorship #TranslationalResearch #cancer

English
0
3
16
1.8K
Lung-MAP retweetledi
SWOG Cancer Research Network
SWOG Cancer Research Network@SWOG·
Next-generation sequencing (NGS) of tumors has become a standard part of the treatment process for most patients with #NSCLC. @LungMAP 3.0 can use results of a patient’s prior NGS testing to assign the patient to a targeted Lung-MAP sub-study. lung-map.org #lcsm
SWOG Cancer Research Network tweet media
English
0
5
7
520
Lung-MAP retweetledi
SWOG Cancer Research Network
SWOG Cancer Research Network@SWOG·
Thank you to Marcia Horn, representing @METCrusaders (and @SWOG patient advocate) for sharing her insights & wisdom in the @LungMAP webinar "Advocating, Accelerating, and Amplifying Lung Cancer Discovery." Recording is at bit.ly/43cRtzo
Lung-MAP@LungMAP

A recording of the May 14th @LungMAP Advocacy Webinar is online at bit.ly/43cRtzo. Featuring a panel discussion with @CancerResrch's Ryan Hohman, @LUNGevity's @aesfCEO, Marcia Horn of @Exon20Group & @WarOnCancer, and @lcfamerica's Kim Norris. #lcsm #lungcancer @SWOG

English
0
4
6
818
Lung-MAP
Lung-MAP@LungMAP·
The @ASCOPost discusses #ASCO25 presentations on S2302 Pragmatica-Lung, a groundbreaking phase 3 trial launched based on findings of phase 2 @LungMAP sub-study S1800A. #NSCLC #lcsm
SWOG Cancer Research Network@SWOG

Thanks to @ASCOPost for highlighting the lessons for #clinicaltrials that have come from this study, presented at #ASCO25: SWOG S2302 Pragmatica-Lung Study Design Still Significant Even With Negative Results in Advanced NSCLC ascopost.com/news/june-2025…

English
0
0
1
126
Lung-MAP
Lung-MAP@LungMAP·
A recording of the May 14th @LungMAP Advocacy Webinar is online at bit.ly/43cRtzo. Featuring a panel discussion with @CancerResrch's Ryan Hohman, @LUNGevity's @aesfCEO, Marcia Horn of @Exon20Group & @WarOnCancer, and @lcfamerica's Kim Norris. #lcsm #lungcancer @SWOG
Friends of Cancer Research@CancerResrch

Advancements in clinical trials have enabled therapies to become first-line treatments. In the last 15 years, clinical trials have been the gold standard. Watch the @LungMAP Advocacy Webinar live at bit.ly/43cRtzo. #lcsm #lungcancer

English
0
3
7
2.5K
Lung-MAP retweetledi
Devika Das, MD, MSHQS, FASCO
Devika Das, MD, MSHQS, FASCO@DevikaDasMD·
Great to see results from @LungMAP S1900E 📍Despite smaller subgroups, it’s quite clear that the cohort with STK11 co mutation does not respond as well with sotorasib. Congratulations to Dr.Padda and team. #lcsm #ASCO25
Devika Das, MD, MSHQS, FASCO tweet mediaDevika Das, MD, MSHQS, FASCO tweet mediaDevika Das, MD, MSHQS, FASCO tweet mediaDevika Das, MD, MSHQS, FASCO tweet media
English
0
1
1
306

Keşfet

@SWOG @FNIH_Org @CancerResrch @theNCI @BaptistOnline @MissouriBaptist @KarenReckampMD @osuccc